Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease

Why is Ferrero buying WK Kellogg? How did Nvidia reach $4 trillion valuation? What impact will Trump’s Brazil tariffs have? Why is Tesla delaying its shareholder meeting? How are tariffs affecting US inflation? Why did Linda Yaccarino resign from X? What caused Delta’s recent stock rally?

Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease

benzinga.com/news/health-care/25/07/46340589/pelthos-launches-first-at-home-gel-contagious-skin-disease

Pelthos Therapeutics Inc. (NYSE:PTHS) on Thursday announced the launch of Zelsuvmi (berdazimer) topical gel 10.3% for molluscum contagiosum (molluscum) in adults and pediatric patients one year of age and older.
Zelsuvmi received a Novel Drug designation from the U.S. Food and Drug…

This story appeared on benzinga.com, 2025-07-10 12:13:33.